Lunger John bought ADAP
January 15, 2024 · Form 4 insider transaction
Lunger John bought 2,544,432 shares of ADAPTIMMUNE THERAPEUTICS PLC at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,544,432
Price
$0.00
Total value
N/A
InsiderLunger John
Role—
SecurityOption to purchase Ordinary Shares
Transaction codeA: Grant or award
Transaction dateJanuary 15, 2024
Filing dateJanuary 17, 2024
Shares owned after2,544,432
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The exercise price was converted from GBP0.11 based on an exchange rate of U.S.$ 1.274570 to GBP1.00. The actual exercise price will be the pounds sterling amount.; Exercisable as to 636,108 Ordinary Shares on January 15, 2025 and will be exercisable as to the remainder in monthly installments of 53,004 Ordinary Shares on the fifteenth of each month from February 15, 2025 through December 15, 2027 and 53,184 Ordinary Shares on January 15, 2028.